Rapid Involution of Large Cardiac Rhabdomyomas With Everolimus Therapy

World J Pediatr Congenit Heart Surg. 2021 May;12(3):426-429. doi: 10.1177/2150135118822711. Epub 2019 May 9.

Abstract

Rhabdomyoma of the fetal heart is a rare disease accounting for about 1% of all fetal cardiac structural anomalies. They are often found in association with tuberous sclerosis complex. Large cardiac rhabdomyomas can compromise the cardiac function. We report a case of multiple large rhabdomyomas of the right and left ventricles, affecting the cardiac function, which was successfully treated with the chemotherapeutic and immunosuppressive medication everolimus, in a neonate with genetically confirmed tuberous sclerosis complex with multisystem manifestations. There was rapid involution of the tumors in response to everolimus therapy in this infant.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents* / therapeutic use
  • Everolimus / therapeutic use
  • Heart Neoplasms* / diagnostic imaging
  • Heart Neoplasms* / drug therapy
  • Humans
  • Infant
  • Infant, Newborn
  • Rhabdomyoma* / diagnostic imaging
  • Rhabdomyoma* / drug therapy
  • Tuberous Sclerosis* / drug therapy

Substances

  • Antineoplastic Agents
  • Everolimus